But these four hub genes were all highly expressed in ccRCC, so we selected TGFB1, TIMP1 and VIM as our research focus, which have great potential as prognosis biomarkers for ccRCC. This evidence concerns the gene TIMP1 and nonpapillary renal cell carcinoma.